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Abstract
Purpose: The Scedosporium apiospermum species complex usually ranks second 
among the filamentous fungi colonizing the airways of patients with cystic fibrosis (CF), 
but little is known about the molecular epidemiology of the airway colonization.
Methods: Polymerase chain reaction (PCR) amplification of repetitive sequences (rep-
PCR) was applied to the retrospective analysis of a panel of isolates already studied by 
random amplification of polymorphic DNA (RAPD) and comprising 63 isolates recovered 
from sputa from 9 CF patients. Results were compared to those obtained previously by 
RAPD, and herein by beta-tubulin (TUB) gene sequencing and Multilocus Sequence 
Typing (MLST).
Results: Within the panel of isolates studied, S. apiospermum sensu stricto and Sce-
dosporium boydii, as expected, were the predominant species with 21 and 36 isolates, 
respectively. Four isolates from one patient were identified as Scedosporium auranti-
acum, whereas two isolates belonged to the Pseudallescheria ellipsoidea subgroup of S. 
boydii. rep-PCR analysis of these isolates clearly differentiated the three species and P. 
ellipsoidea isolates, whatever the rep-PCR kit used, and also permitted strain differen-
tiation. When using the mold primer kit, results from rep-PCR were in close agreement 
with those obtained by MLST. For both S. apiospermum and S. boydii, 8 genotypes were 
differentiated by rep-PCR and MLST compared to 10 by RAPD. All S. aurantiacum isolates
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shared the same RAPD genotype and exhibited the same rep-PCR profile and sequence
type.
Conclusions: These results illustrate the efficacy of rep-PCR for both species identification
within the S. apiospermum complex and genotyping for the two major species of this
complex.
Abstract presentation: Part of this work was presented during the 18th Congress of the
International Society for Human and Animal Mycology, Berlin (Germany), June 2012.
S. Giraud, C. Godon, A. Rougeron, J.P. Bouchara and L. Favennec are members of the
ECMM/ISHAM working group on Fungal respiratory infections in Cystic Fibrosis (Fri-CF).
Key words: Scedosporium apiospermum species complex, Cystic fibrosis, Species identification, Genotyping,
rep-PCR.
Introduction
Prognosis in cystic fibrosis (CF), the major inherited dis-
ease in the Caucasian population, mainly depends on the
severity of the lesions of the lungs. Because of the thicken-
ing of the bronchial mucus and of the impairment of the
mucociliary clearance, the respiratory tract of CF patients
is often colonized by various microorganisms, sometimes
leading to respiratory infections which are the major cause
of morbidity and mortality in this context.1 Considerable
attention has been paid during the past decades to the pre-
vention and treatment of bacterial respiratory infections,
and progress in this field resulted in a marked increase in
life expectancy.2 Nevertheless, continued improvement in
life expectancy requires a better knowledge of the causative
agents of these infections and greater attention should be
paid to nonbacterial pathogens, especially fungi.3
With a frequency ranging from 4.5% to 11.6%, Sce-
dosporium apiospermum, which was initially considered
the anamorph of Pseudallescheria boydii, usually ranks sec-
ond among the filamentous fungi colonizing the CF airways,
after Aspergillus fumigatus.4–7 In CF, this fungal coloniza-
tion may result in endobronchitis and allergic broncho-
pulmonary mycoses.4,8 Moreover, it may compromise the
success of lung transplantation due to the capacity of the
fungus to cause severe and often fatal disseminated infec-
tions in immunocompromised individuals9–11 and to the
limited efficacy of current antifungals.12–14
Limited information is presently available regarding the
natural history of the airway colonization by S. apiosper-
mum in CF. Recent taxonomic studies revealed that S.
apiospermum and P. boydii are two distinct species, and
three additional species were identified.15–17 Therefore, S.
apiospermum is now considered a species complex com-
prising five distinct species, namely Scedosporium apiosper-
mum sensu stricto, Scedosporium aurantiacum, Scedospo-
rium dehoogii, P. boydii (including the Pseudallescheria
ellipsoidea subgroup), and Pseudallescheria minutispora,
which are now called Scedosporium boydii and Scedospo-
rium minutisporum.18 Regarding the molecular epidemiol-
ogy of airway colonization / respiratory infections in CF, it
was shown that apart from S. dehoogiiwhich has never been
reported in respiratory diseases, all these fungi are usually
responsible for a chronic colonization of the airways.19,20
However, these results were obtained by random amplifi-
cation of polymorphic DNA (RAPD) which is considered
a poorly reproducible method. A multi-locus sequence typ-
ing (MLST) scheme has been proposed for genotype studies,
based on the sequencing of five distinct loci.21 Recently, the
semi-automated DiversiLab system based on polymerase
chain reaction (PCR) amplification of repetitive sequences
(rep-PCR) followed by separation of the amplified products
by capillary electrophoresis has been successfully applied
to species identification in various fungal groups including
Candida yeasts, Aspergillus and Fusarium species,22–24 as
well as to strain differentiation within Candida and As-
pergillus species.23,25 Here this method was applied to the
retrospective analysis of multiple or sequential isolates be-
longing to the S. apiospermum species complex recovered
from sputum samples collected from CF patients, and pre-
viously analyzed by RAPD, and results were compared
to those obtained by beta-tubulin gene sequencing and
MLST.
Materials and methods
Microorganisms and culture conditions
This study was performed using a panel of 63 multiple
(from the same clinical sample) or sequential (from suc-
cessive samples from the same patient) isolates recovered
from sputum samples collected from nine CF patients, and
previously studied by RAPD20 (Table 1). Among this set
of isolates, RAPD differentiated 12 genotypes; a unique
genotype was found for seven patients, while one patient
(Patient P1) exhibited a largely dominant genotype
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Table 1. Isolates studied and their rep-PCR genotypes compared to previously determined RAPD genotypes and to herein
identified MLST sequence types.
Genbank rep-PCR genotype3
Patient Sampling date IHEM Species accession Mold Aspergillus MLST RAPD
number1 (yyyy/mm/dd) number identification number2 kit kit ST genotype1
P1 1998/01/09 14263 S. boydii AJ889990 3 5 10 1
14264 S. boydii KC812533 3 5 10 1
14266 S. boydii KC812534 3 5 10 1
14267 S. boydii KC812535 3 5 10 1
1998/02/16 14369 S. boydii KC812536 3 5 10 1
1998/03/10 14457 S. boydii KC812537 3 5 10 1
1998/06/10 14638 S. boydii AJ889998 3 5 10 2
1998/07/31 14756 S. boydii KC812538 3 5 10 1
14758 S. boydii AJ890000 3 5 10 3
14759 S. boydii KC812539 3 5 10 1
1998/09/04 15142 S. boydii KC812540 3 5 10 1
1999/01/13 15582 S. boydii KC812541 3 5 10 1
15583 S. boydii KC812542 3 5 10 1
P2 1999/01/13 49900353/14 P. ellipsoidea KC812543 7 8 / 4
49900353/24 P. ellipsoidea KC812544 7 8 / 4
P3 1998/02/24 14452 S. boydii KC812545 4 5 3 5
14453 S. boydii KC812546 4 5 3 5
14455 S. boydii KC812547 4 5 3 5
1998/05/26 14624 S. boydii KC812548 4 5 3 5
14626 S. boydii KC812549 4 5 3 5
14627 S. boydii KC812550 4 5 3 5
1998/06/06 14628 S. boydii KC812551 4 5 3 5
14629 S. boydii KC812552 4 5 3 5
14631 S. boydii KC812553 4 5 3 5
14632 S. boydii KC812554 4 5 3 5
1998/06/15 14633 S. boydii KC812555 4 5 3 5
14634 S. boydii KC812556 4 5 3 5
14635 S. boydii KC812557 4 5 3 5
14636 S. boydii KC812558 4 5 3 5
14637 S. boydii KC812559 4 5 3 5
1998/11/09 15464 S. boydii KC812560 4 5 3 5
P4 1998/01/08 14268 S. apiospermum AJ889991 8 3 37 6
14269 S. apiospermum KC812561 8 3 37 6
14270 S. apiospermum KC812562 8 3 37 6
1998/01/21 14273 S. apiospermum KC812563 8 3 37 6
14275 S. apiospermum KC812564 8 3 37 6
14276 S. apiospermum KC812565 8 3 37 6
1999/02/15 15643 S. apiospermum KC812566 8 3 37 6
P5 1998/09/22 15149 S. apiospermum AJ890002 9 4 39 8
15151 S. apiospermum KC812567 9 4 39 8
P6 1998/10/26 15458 S. aurantiacum AJ890135 2 6 47 9
15459 S. aurantiacum KC812568 2 6 47 9
15460 S. aurantiacum KC812569 2 6 47 9
15461 S. aurantiacum KC812570 2 6 47 9
P7 1998/01/19 14357 S. boydii KC812571 6 5 11 10
1998/09/22 15545 S. boydii KC812572 6 5 11 10
P8 1998/03/04 14462 S. apiospermum AJ889995 10 1 38 11
14463 S. apiospermum KC812573 10 2 38 11
14465 S. apiospermum KC812574 10 1 38 11
1998/08/11 14762 S. apiospermum KC812575 11 4 36 12
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Table 1. – continued
Genbank rep-PCR genotype3
Patient Sampling date IHEM Species accession Mold Aspergillus MLST RAPD
number1 (yyyy/mm/dd) number identification number2 kit kit ST genotype1
14763 S. apiospermum KC812576 11 4 36 12
14764 S. apiospermum KC812577 11 4 36 12
1998/09/22 15146 S. apiospermum KC812578 11 4 36 12
15148 S. apiospermum KC812579 11 4 36 12
1998/11/10 15551 S. apiospermum KC812580 11 4 36 12
15552 S. apiospermum KC812581 11 4 36 12
15553 S. apiospermum KC812582 10 4 38 11
1998/12/03 15555 S. apiospermum KC812583 11 4 36 12
P9 1998/02/16 14358 S. boydii AJ889993 5 5 12 15
14359 S. boydii KC812584 5 5 12 15
14360 S. boydii KC812585 5 5 12 15
14361 S. boydii JQ691025 5 5 12 15
14362 S. boydii KC812586 5 5 12 15
Environment5 1991 21148 S. minutisporum AJ890122 1 7 / /
1Patient numbers and RAPD genotypes as previously published.20
2Accession numbers correspond to the nucleotide sequence of TUB region of the beta-tubulin gene which was sequenced for all isolates in this work, except
italicized numbers which correspond to TUB sequences deposited in Genbank by Gilgado et al.15
3rep-PCR genotypes were numbered according to their order in the corresponding phylogenetic trees (see Fig. 3).
4Isolates not deposited at the IHEM culture collection and designated by Angers University Hospital (Angers, France) identification number.
5Type strain of S. minutisporum (also called FMR 4072) isolated in 1991 from sediment from Tordera river (Barcelona, Spain) and identified as S. minutisporum
by Gilgado et al.15
associated with two others, each found only once, and two
distinct genotypes were detected successively, but once asso-
ciated, for the last patient (Patient P8). No genotypes were
shared by the patients. These isolates preserved by freeze-
drying in our laboratory and deposited at the Institute of
Hygiene and Epidemiology-Mycology section (IHEM) cul-
ture collection (Scientific Institute of Public Health, Brus-
sels, Belgium), were initially identified on a morphological
basis as belonging to the S. apiospermum complex. Ad-
ditionally, the type strain of S. minutisporum 21148, iso-
lated from sediments from the Tordera river (Barcelona,
Spain)15 and obtained from the IHEM culture collection
was included in our set of isolates.
Isolates were cultivated on yeast extract-peptone-
dextrose (YPD) agar (containing in g/l: yeast extract, 5;
peptone, 10; glucose, 20; and agar, 20) plates supplemented
with 0.5 g/l chloramphenicol. After incubation (7 days,
37◦C), the mycelium was scraped and inoculated in YPD
broth. Cultures were incubated for 10 days at 37◦C. Finally
the fungal mat was harvested and ground with a mortar
and pestle in liquid nitrogen.
Repetitive sequence-based PCR
Fungal DNA was extracted from ground mycelium using
the MO-BIO Ultraclean preparation kit (Ozyme, Saint-
Quentin en Yvelines, France). DNA was quantified at
260 nm using a Nanodrop spectrophotometer (NanoDrop
technologies, Wilmington, DE). Repetitive DNA sequences
were amplified by PCR using two primer sets from
bioMe´rieux (Craponne, France): the Mold DNA finger-
printing primer kit proposed for the analysis of all mold
species, and the Aspergillus-specific DNA fingerprinting
primer kit which uses primers specifically designed for A.
fumigatus. Amplicons were separated by capillary elec-
trophoresis and electrophoretic profiles were compared
using the DiversiLab Healthcare software version 3.41
(bioMe´rieux). Phylogenetic trees were established using the
unweighted pair group method with arithmetic mean (UP-
GMA). The interpretative criteria provided by the manu-
facturer led us to categorize the isolates as indistinguish-
able, closely related or different (DiversiLab user’s guide).
Isolates with electrophoretic profiles differing by at least
three peaks were categorized as different. Isolates were cat-
egorized as indistinguishable and belonging to the same
genotype when they shared the same electrophoretic pro-
file, and isolates with electrophoretic profiles differing by
one or two bands were categorized as closely related. Rep-
PCR genotypes were numbered according to their order in
the phylogenetic trees.
Species identification within the S. apiospermum
complex
Molecular identification was performed as described
by Zouhair et al.19 by PCR amplification of part of
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the beta-tubulin gene (TUB). Amplified products were
purified using the NucleoSpin extract II kit (Macherey-
Nagel, Hoerdt, France) and commercially sequenced in
both directions. The obtained sequences were analyzed by
individual BLASTn (Basic Local Alignment Search Tool)
searches using the NCBI (National Center for Biotechnol-
ogy Information) BLAST database. Ninety-nine to 100%
sequence similarities to isolates FMR 8630, FMR 4072,
FMR 8535, FMR 8537, and FMR 7884 analyzed by Gil-
gado et al.15 were used to identify the present isolates as
S. aurantiacum, S. minutisporum, S. apiospermum, S. boy-
dii, and P. ellipsoidea, respectively. All sequences were de-
posited in the Genbank database under the accession num-
bers indicated in Table 1.
Multilocus Sequence Typing (MLST)
All S. boydii not including P. ellipsoidea (n = 36), S.
apiospermum (n = 21) and S. aurantiacum isolates (n = 4)
were analyzed by MLST as previously described by Bern-
hardt et al.21 or according to recommendations of the
Fungal MLST Database (http://mlst.mycologylab.org/) for
S. aurantiacum isolates. For all the isolates, DNA was
amplified by PCR using five primer pairs targeting part
of the genes encoding actin (ACT), calmodulin (CAL,
exon 3–4), the second largest subunit of RNA poly-
merase II gene (RPB2), ß-tubulin (BT2, exon 2–4) and
the manganese superoxide dismutase (SOD2). Moreover,
for S. aurantiacum isolates, an additional sequence in
the elongation factor 1 alpha (EF1α) gene was ampli-
fied. In addition, to optimize the amplification of RPB2
and BT2 loci for S. apiospermum isolates, two new
primer pairs were designed from the whole genome se-
quence of S. apiospermum strain IHEM 1446226: RPB2–
5F 5′-GACGACCGTGATCACTTTGG-3′ and RPB2–7R
5′-CCCATGGCTGACTGGTAA-3′ for RPB2 and BT2a
5′-GGAAACCAAATTGGTGCTGCCTTC-3′ and BT2b 5′-
ACCCTCTGTGTAGTGACCCTTGGC-3′ for BT2 ampli-
fication.
Amplified products were purified using the NucleoSpin
extract II kit (Macherey-Nagel) and commercially se-
quenced in both directions. Sequencing analysis was per-
formed using the BioEdit sequence Alignment Editor (ver-
sion 7.1.11) and the sequences were trimmed as previously
described by Bernhardt et al.21 The sequence type (ST) of
each isolate was defined by the combination of alleles iden-
tified at the different loci studied. All obtained data were
deposited in the Genbank database and submitted to the
Fungal MLST Database.
Results
Species identification within the S. apiospermum
complex
TUB sequencing was used for precise species identification
within the S. apiospermum complex. Scedosporium boydii
was the most common species with a total number of 36
isolates recovered from 15 sputum samples collected from
patients P1, P3, P7, and P9, whereas S. apiospermum was
identified from three patients (P4, P5, and P8), represent-
ing 21 isolates (Table 1). All isolates from patient P6 were
identified by TUB sequencing as S. aurantiacum, whereas
the two isolates studied for patient P2were reassigned to the
P. ellipsoidea subgroup of S. boydii. Scedosporium
minutisporum was not recovered from the nine CF patients
studied here, and none of the patients was colonized by two
distinct species.
Performances of Mold and Aspergillus rep-PCR
assays and criteria for strain comparison
rep-PCR was conducted on our set of isolates using two
primer kits designed to amplify all mold species (MoldDNA
fingerprinting primer kit) or more specifically A. fumigatus
(Aspergillus-specific DNA fingerprinting primer kit), and
from the obtained electrophoretic profiles, the isolates were
categorized as indistinguishable, closely related or differ-
ent according to the interpretative criteria provided by the
manufacturer. An example of isolates sharing the same elec-
trophoretic profile and therefore belonging to the same rep-
PCR genotype is presented in Figure 1A with S. apiosper-
mum IHEM 14762 and 14763 isolates obtained from the
same sputum sample from patient P8. Figure 1B shows an
example of closely related isolates, that is, differing only
by 1 or 2 peaks, with S. apiospermum IHEM 14273 and
15149 isolates from patients P4 and P5, respectively, and
an example of isolates with -electrophoretic profiles differ-
ing by at least three peaks, therefore belonging to different
genotypes, is shown in Figure 1C, with S. apiospermum
IHEM 14270 and 15146 isolates recovered from patients
P4 and P8, respectively.
The use of the Mold primer kit always resulted in the
detection of a greater number of electrophoretic bands
as shown for S. boydii IHEM 14636 and S. auranti-
acum IHEM 15461 isolates presented as typical examples
(Fig. 2). Moreover, this kit was more discriminant than
the Aspergillus-specific primer kit. Seven different profiles
were obtained for the whole set of clinical isolates using the
Aspergillus-specific primer kit, compared to 10 genotypes
identified with the Mold primer kit (Table 1). Finally, as no
S. minutisporum isolates were detected among the clinical
t
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Figure 1. Typical examples of electrophoretic profiles obtained by rep-PCR using the Mold DNA fingerprinting primer kit. (A) identical profiles (S.
apiospermum IHEM 14762 and 14763 isolates); (B) closely related profiles (S. apiospermum 14273 and 15149 isolates); and (C) distinct profiles (S.
apiospermum IHEM 14270 and 15146 isolates).
isolates studied here, an environmental isolate was analyzed
by rep-PCR, which clearly differentiated this isolate from
the others.
In addition, data were analyzed using the DiversiLab
software, which generates dendrograms showing finger-
print similarities between the isolates. All isolates from the
same species were clustered in the dendrogram generated
from data obtained with the Mold primer kit (Fig. 3A) as
well as using the Aspergillus-specific primer kit (Fig. 3B).
With both primer kits, two groups of isolates were dis-
tinguished within S. apiospermum sensu stricto. However,
compared to theMold primer kit, the use of theAspergillus-
specific primer kit separated the species in a slightly different
order. For instance, whereas the two P. ellipsoidea isolates
were clustered with the other S. boydii isolates with the
Mold primer kit, they were clearly separated from the other
S. boydii isolates when using the Aspergillus-specific primer
kit (Fig. 3B).
Comparison of rep-PCR wit MLST and RAPD for
strain differentiation
Compared to the Aspergillus-specific primer kit, the use of
the mold primer kit provided results more consistent with
those obtained by RAPD and MLST (Table 1). For exam-
ple, the Aspergillus rep-PCR assay could not differentiate
the S. boydii isolates, always producing for these isolates the
same electrophoretic profile. In contrast, results obtained
using the Mold primer kit were in close agreement with
those obtained by MLST. Using this kit, rep-PCR showed
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Figure 2. Comparison of electrophoretic profiles generated using the Mold DNA fingerprinting primer kit (A) or with the Aspergillus-specific finger-
printing primer kit (B). Electrophoretic profiles obtained for S. boydii IHEM 14636 and S. aurantiacum IHEM 15461 isolates are shown as examples.
that patients P3, P7 and P9 were each colonized by a single
genotype, differing from one patient to another, as demon-
strated by RAPD and MLST. Conversely, while three geno-
types were identified by RAPD for patient P1 with a largely
dominant genotype (11 isolates) associated with two other
genotypes very close to the dominant genotype and found
only once each, single electrophoretic profile and sequence
type were seen by rep-PCR and MLST for all isolates from
this patient.
Regarding S. apiospermum sensu stricto, patients P4 and
P5 were also colonized each by a single strain as suggested
by rep-PCR, which was confirmed by RAPD and MLST.
By contrast, two distinct rep-PCR genotypes were found
successively in sputum samples from patient P8 using the
Mold primer kit, with at first a transient carriage of Mold
rep-PCR genotype 10 unable to establish within the respira-
tory tract, followed by a chronic colonization of the airways
by Mold rep-PCR genotype 11, and a similar evolution was
revealed by RAPD and MLST. Likewise, three distinct elec-
trophoretic profiles were seen with the Aspergillus-specific
primer kit for the four isolates belonging toMLST sequence
type 38.Moreover, using theAspergillus-specific primer kit,
the same electrophoretic profile was seen for patient P5’s
isolates and most of the isolates from patient P8, whereas
the use of the Mold primer kit clearly differentiated the iso-
lates from these two patients, in agreement with the results
obtained by RAPD and MLST.
Four S. aurantiacum isolates originating from the same
sputum sample from patient P6were also studied.Whatever
the rep-PCR primer kit used, these isolates shared the same
electrophoretic profile and therefore belonged to the same
genotype, in agreement with the results obtained by RAPD
and MLST.
Moreover, as they belonged to the P. ellipsoidea sub-
group of S. boydii, the two isolates studied for patient P2
were not analyzed by MLST. Nevertheless, in agreement
with results from RAPD, both isolates were shown to be-
long to the same genotype by rep-PCR.
Discussion
In most cases, the airway colonization by species of the
S. apiospermum complex in CF is asymptomatic.3,4 How-
ever, even in the absence of an obvious respiratory infection,
careful attention is required in case of chronic colonization
of the airways, because of the propensity of these fungi to
disseminate in lung transplant recipients9–11 and of their
primary resistance to echinocandins and very low suscep-
tibility to current triazole drugs.12–14 Additionally, there is
now accumulating evidence indicating that persistent car-
riage of fungi in CF patients without clinical signs of respi-
ratory infection is a risk factor for a progressive worsening
of the lung function.27–29 Compared to non-colonized pa-
tients and transient carriers, the chronic colonization of
8 Medical Mycology, 2015, Vol. 00, No. 00
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Figure 3. Phylogenetic tree generated from the analysis of data obtained with the Mold DNA fingerprinting primer kit (A) or with the Aspergillus-
specific fingerprinting primer kit (B). Data were analyzed with the unweighted pair groupmethodwith arithmetic mean (UPGMA) using the DiversiLab
Healthcare software and genotypes were numbered according to their order in the phylogenetic trees. The type strain of S. minutisporum (IHEM
strain 21148, also called FMR 4072) was included in the panel of isolates studied.
the airways by A. fumigatus or Candida albicans is an
independent risk factor for a decline in the forced expi-
ratory volume in one second (FEV1) and hospital-treated
exacerbations in CF.27–29 Therefore an early and accu-
rate detection of fungi appears essential for appropriate
treatment.
Since the works of Gilgado et al.15–17, S. apiosper-
mum is considered a species complex comprising five
distinct species, four of them having been identified in
the CF context: S. apiospermum sensu stricto, S. boy-
dii, S. aurantiacum, and S. minutisporum.19 The precise
species identification within the S. apiospermum complex is
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important not only for a better knowledge of the epidemi-
ology of airway colonization / clinical infections but also
because of differences between species in their susceptibility
to antifungals and pathogenicity.12–14,30 However, precise
species identification is not possible on a morphological ba-
sis. Several molecular methods allowing the detection of the
S. apiospermum complex from respiratory secretions and,
for some of them, direct species identification, have been
described such as quantitative real-time PCR, PCR-based
reverse line blot hybridization and loop-mediated isother-
mal amplification.31 Nevertheless, these methods are not
commercially available and therefore uneasy to use in rou-
tine practice. A rapid and accurate species differentiation
from positive cultures may be reached by matrix-assisted
LASER desorption ionization time-of-flight / mass spec-
trometry, but until now validated databases for identifi-
cation of these closely related species are available for the
Andromas system only.32,33 In addition, previous genotype
studies onA. fumigatus orAspergillus terreus in CF demon-
strated that genotyping of multiple and sequential isolates is
required to distinguish between a regular, but transient car-
riage of distinct genotypes, which is not clinically relevant,
from a chronic colonization of the airways, which indicates
growth and proliferation of the fungus in the CF airways,
and therefore its contribution to the inflammatory reaction
and to a clinical or functional worsening.34,35 However,
none of the above mentioned methods allows this strain
delineation.
In the present study, rep-PCR permitted precise species
identification of clinical isolates from CF patients within
the S. apiospermum complex as previously shown for the
two major species of this complex, that is, S. apiospermum
sensu stricto and S. boydii.36 In addition we also demon-
strated that this method may be used for strain delineation
within this species complex, at least for the two major
species. Species identification and strain delineation were
found easier using the Mold DNA fingerprinting primer kit
than the Aspergillus-specific primer kit, which always pro-
duced lower peak numbers and was less discriminant. These
two kits never were compared in previous studies performed
on evaluation of the performances of rep-PCR for identi-
fication and/or strain differentiation for fungi. Apart from
the work of Healy et al.,23 the Mold DNA fingerprinting
primer kit was the only one used in studies on filamentous
fungi.24,36 Nevertheless, it is likely that the primers included
in the Aspergillus-specific kit are too distant from the tar-
get DNA sequences on other fungal species, and one may
recommend the use of the Mold kit for studies on non-
Aspergillus filamentous fungi.
Interestingly, rep-PCR data were consistent with species
identification and a close agreement was shown for strain
differentiation between rep-PCR and MLST. Dendrogram
analysis of the data generated with the Mold primer kit
revealed a clustering very close to that reported by Gil-
gado et al.15 Interestingly, species clustered in a different
order using the Aspergillus-specific primer kit, with the two
P. ellipsoidea isolates clearly separated from the other S.
boydii isolates. rep-PCR thus provides new experimental
data reviving the debate about the species status of P.
ellipsoidea.18
From previous analysis of our set of isolates by RAPD,
it was suggested that CF patients are usually colonized by a
single genotype conserved over time despite the antifungal
therapy.20 Whatever the species within the S. apiospermum
complex, a single genotype different from one patient to an-
other was continuously present in almost all patients during
their follow-up, and this was confirmed by rep-PCR and
MLST. Interestingly, distinct genotypes were found during
the follow-up in a few cases, with a largely dominant geno-
type responsible for a chronic colonization of the airways
and one or two others unable to establish within the respi-
ratory tract. Previous studies performed on the molecular
epidemiology of the airway colonization by A. fumigatus
or A. terreus in CF also showed some genotypes unable to
chronically colonize the respiratory tract and disappearing
in later samples for a genotype better adapted to the CF
lungs.34,35
Genotyping is also crucial for epidemiological purposes.
Species of the S. apiospermum complex are worldwide-
distributed filamentous fungi, but the origin of patients’
contamination is still unknown. An environmental study
performed in Austria and the Netherlands showed that
S. apiospermum is the most frequent species in indus-
trial areas, city parks and playgrounds and agricultural
areas.37 In contrast, S. boydii was found the major species
in a French cohort of CF patients colonized by the S.
apiospermum complex.19 rep-PCR, which allows both
species identification and genotype analysis, should facil-
itate the comparison of clinical and environmental iso-
lates and thus the identification of the origin of patients’
contamination.
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